stars 1 stars 2 stars 3

Gyntools is dedicated to ending the unnecessary suffering caused by misdiagnosed vaginitis. Our flagship Gyni™, an AI automated, point-of-care system, streamlines accurate vaginitis diagnosis, bringing expert-level diagnosis to every clinic. Up to 50% of cases are misdiagnosed on the first clinic visit, costing $1.6 Billion per year to payers and putting patients at risk of STDs, pre-term birth, and infertility. Gyni liberates women from the pain, frustration, and potentially devastating side effects of misdiagnosed vaginitis, ending the need for unnecessary follow-up visits and allowing for the immediate start of an effective treatment plan. We deploy the power of machine learning to accurately determine within 5 mins whether a woman is suffering from Bacterial Vaginosis; Candida Albicans; Candida non-albicans; Trichomoniasis; Vaginal Atrophy / GSM (Genitourinary Syndrome of Menopause); Cytolytic Vaginosis; or Aerobic Vaginitis / DIV (Desquamative Inflammatory Vaginitis). The Gyni system is able to imitate the diagnostic process of vulvovaginal experts and allows non expert operators to provide the highest level of diagnosis. Gyni is CE-marked and AMAR registered, with active sales in Israel and Europe. FDA clearance is pending.

GynTools Questions

Nimrod Lev is the CEO, Co-Founder of GynTools.

4 people are employed at GynTools.

Top GynTools Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users